Joshua Levin, PhD, is a senior group leader and research scientist in the Broad Institute of MIT and Harvard’s Stanley Center for Psychiatric Research, as well as in the Klarman Cell Observatory. In his research, he uses transcriptomic approaches to improve our understanding of brain function as it relates to disorders such as autism, schizophrenia, and Parkinson’s disease.
During his time at the Broad Institute, Dr. Levin has developed and comprehensively evaluated an extensive portfolio of RNA sequencing (RNA-Seq) methods such as targeted, strand-specific, total, low-input, 5’ end, and single cell RNA-Seq protocols. His group performed single cell RNA-Seq in a seminal study on single-cell level heterogeneity in immune cells.
More recently, Dr. Levin has been instrumental in neuroscience studies—transcriptional profiling of samples from autism patients and single cell RNA-Seq of mouse thalamic reticular nucleus and human brain organoids.